(THE EPOCH TIMES) – The U.S. Food and Drug Administration (FDA) has reported a shortage of the injectable version of penicillin, citing increased demand for the antibiotic.
In a notice on April 26, the agency said there are shortages of Pfizer’s Bicillin L-A in both regular and pediatric versions. It said the shortage may persist until around the last quarter of the year.
WND is now on Trump's Truth Social! Follow us @WNDNews
Bicillin L-A is Pfizer’s brand name for penicillin G benzathine, which is administered by injection intramuscularly. Pfizer is the sole supplier of penicillin G benzathine in the United States.
The post FDA reports shortages of type of penicillin used to treat syphilis, strep throat appeared first on WND.
